Teva and Sanofi Announce Duvakitug (Anti-TL1A) Positive Phase 2b Results Demonstrating Best-in-Class Potential in Ulcerative Colitis and Crohn’s Disease

Teva and Sanofi Announce Duvakitug (Anti-TL1A) Positive Phase 2b Results Demonstrating Best-in-Class Potential in Ulcerative Colitis and Crohn’s Disease

Notified -...

Casey House creates fictitious drug, Stigmavir, to smash HIV stigma within the health care system

Casey House creates fictitious drug, Stigmavir, to smash HIV stigma within the health care system

...

Anti-Drone Industry Size is Anticipated to Gain $3.8 Bn by

Anti-Drone Industry Size is Anticipated to Gain $3.8 Bn by

Chicago, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Anti-Drone Industry by Technology (Electronic, Laser, and Kinetic Systems), Application (Detection, Detection......

menu
menu